{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:59:13Z","timestamp":1775019553133,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This study was supported by Sanofi Genzyme Spain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00296-019-04378-6","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T10:20:41Z","timestamp":1565259641000},"page":"2015-2024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-6692","authenticated-orcid":false,"given":"Antonio","family":"Gomez-Centeno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Rubio-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6300-5341","authenticated-orcid":false,"given":"Juan Gabriel","family":"Ovalles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-7846","authenticated-orcid":false,"given":"Sara","family":"Manrique-Arija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-3854","authenticated-orcid":false,"given":"Sara","family":"Marsal-Barril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Amarelo-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3145-6137","authenticated-orcid":false,"given":"Javier","family":"del Pino-Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagrario","family":"Bustabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceferino","family":"Barbaz\u00e1n-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"key":"4378_CR1","volume-title":"Harrison\u2019s rheumatology","author":"AS Fauci","year":"2013","unstructured":"Fauci AS, Langford CA, Langford C (2013) Harrison\u2019s rheumatology. McGraw-Hill Publishing, New York"},{"issue":"25","key":"4378_CR2","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1056\/NEJMra040226","volume":"350","author":"JR O\u2019Dell","year":"2004","unstructured":"O\u2019Dell JR (2004) Therapeutic strategies for rheumatoid arthritis. N Engl J Med 350(25):2591\u20132602. \nhttps:\/\/doi.org\/10.1056\/NEJMra040226","journal-title":"N Engl J Med"},{"key":"4378_CR3","first-page":"66","volume":"1760","author":"M Steiner","year":"2010","unstructured":"Steiner M, Mu\u00f1oz Fern\u00e1ndez S (2010) Artritis reumatoide: f\u00e1rmacos modificadores de la enfermedad. Jano Med Humanid 1760:66","journal-title":"Jano Med Humanid"},{"issue":"1","key":"4378_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/rheumatology\/41.1.88","volume":"41","author":"L Carmona","year":"2002","unstructured":"Carmona L, Villaverde V, Hernandez-Garcia C, Ballina J, Gabriel R, Laffon A (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatol (Oxf Engl) 41(1):88\u201395. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/41.1.88","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"7","key":"4378_CR5","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/rheumatology\/ken205","volume":"47","author":"J Carbonell","year":"2008","unstructured":"Carbonell J, Cobo T, Balsa A, Descalzo MA, Carmona L (2008) The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry. Rheumatol (Oxf Engl) 47(7):1088\u20131092. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/ken205","journal-title":"Rheumatol (Oxf Engl)"},{"issue":"7","key":"4378_CR6","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L (2014) The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1316\u20131322. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2013-204627","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4378_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s1699-258x(05)72744-3","volume":"1","author":"MD Ruiz-Montesinos","year":"2005","unstructured":"Ruiz-Montesinos MD, Hernandez-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F (2005) Cost analysis in a cohort of rheumatoid arthritis patients managed in rheumatology units in Spain. Reumatol Clin 1(4):193\u2013199. \nhttps:\/\/doi.org\/10.1016\/s1699-258x(05)72744-3","journal-title":"Reumatol Clin"},{"issue":"11","key":"4378_CR8","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00296-015-3275-4","volume":"35","author":"K Mattila","year":"2015","unstructured":"Mattila K, Buttgereit F, Tuominen R (2015) Influence of rheumatoid arthritis-related morning stiffness on productivity at work: results from a survey in 11 European countries. Rheumatol Int 35(11):1791\u20131797. \nhttps:\/\/doi.org\/10.1007\/s00296-015-3275-4","journal-title":"Rheumatol Int"},{"issue":"3","key":"4378_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/s1699-258x(05)72733-9","volume":"1","author":"MD Ruiz-Montesinos","year":"2005","unstructured":"Ruiz-Montesinos MD, Hernandez-Cruz B, Ariza-Ariza R, Carmona L, Ballina J, Navarro-Sarabia F (2005) Resource utilization in a cohort of rheumatoid arthritis patients attended in rheumatology units in Spain. Reumatol Clin 1(3):142\u2013149. \nhttps:\/\/doi.org\/10.1016\/s1699-258x(05)72733-9","journal-title":"Reumatol Clin"},{"issue":"3","key":"4378_CR10","first-page":"227","volume":"59","author":"L Punzi","year":"2007","unstructured":"Punzi L, Cimmino MA, Frizziero L, Gerloni V, Grassi W, Modena V, Montecucco C, Ramonda R, Schiavon F, Spadaro A, Trotta F (2007) Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis. Reumatismo 59(3):227\u2013234","journal-title":"Reumatismo"},{"issue":"3","key":"4378_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/ard.2003.010298","volume":"63","author":"J van Aken","year":"2004","unstructured":"van Aken J, Lard LR, le Cessie S, Hazes JM, Breedveld FC, Huizinga TW (2004) Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 63(3):274\u2013279. \nhttps:\/\/doi.org\/10.1136\/ard.2003.010298","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4378_CR12","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492\u2013509. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2013-204573","journal-title":"Ann Rheum Dis"},{"issue":"10055","key":"4378_CR13","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/s0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet (Lond Engl) 388(10055):2023\u20132038. \nhttps:\/\/doi.org\/10.1016\/s0140-6736(16)30173-8","journal-title":"Lancet (Lond Engl)"},{"issue":"5","key":"4378_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.reuma.2015.05.001","volume":"11","author":"R Sanmart\u00ed","year":"2015","unstructured":"Sanmart\u00ed R, Garc\u00eda-Rodr\u00edguez S, \u00c1lvaro-Gracia JM, Andreu JL, Balsa A, C\u00e1liz R, Fern\u00e1ndez-Nebro A, Ferraz-Amaro I, G\u00f3mez-Reino JJ, Gonz\u00e1lez-\u00c1lvaro I (2015) Actualizaci\u00f3n 2014 del Documento de Consenso de la Sociedad Espa\u00f1ola de Reumatolog\u00eda sobre el uso de terapias biol\u00f3gicas en la artritis reumatoide. Reumatol Clin 11(5):279\u2013294","journal-title":"Reumatol Clin"},{"issue":"6","key":"4378_CR15","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poor G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-210715","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"4378_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0025-7753(02)72526-8","volume":"118","author":"I Gonz\u00e1lez-\u00c1lvaro","year":"2002","unstructured":"Gonz\u00e1lez-\u00c1lvaro I, Hern\u00e1ndez-Garc\u00eda C, Villaverde Garc\u00eda V, Vargas E, Ortiz AM, emAR GdE (2002) Variabilidad en el tratamiento farmacol\u00f3gico de la artritis reumatoide en Espa\u00f1a. Med Cl\u00edn 118(20):771\u2013776","journal-title":"Med Cl\u00edn"},{"issue":"4","key":"4378_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00296-018-3933-4","volume":"38","author":"FJ Lopez-Longo","year":"2018","unstructured":"Lopez-Longo FJ, Seoane-Mato D, Martin-Martinez MA, Sanchez-Alonso F (2018) Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis. Rheumatol Int 38(4):589\u2013598. \nhttps:\/\/doi.org\/10.1007\/s00296-018-3933-4","journal-title":"Rheumatol Int"},{"issue":"3","key":"4378_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2011-200302","volume":"71","author":"JJ G\u00f3mez-Reino","year":"2012","unstructured":"G\u00f3mez-Reino JJ, Rodr\u00edguez-Lozano C, Campos-Fern\u00e1ndez C, Montoro M, Descalzo M\u00c1, Carmona L (2012) Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10\u00a0years: data from the Spanish registry BIOBADASER 2.0. Ann Rheumat Dis 71(3):382\u2013385","journal-title":"Ann Rheumat Dis"},{"issue":"3","key":"4378_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4081\/reumatismo.2011.155","volume":"63","author":"G Lapadula","year":"2011","unstructured":"Lapadula G, Ferraccioli G, Ferri C, Punzi L, Trotta F (2011) GISEA: an Italian biological agents registry in rheumatology. Reumatismo 63(3):155\u2013164. \nhttps:\/\/doi.org\/10.4081\/reumatismo.2011.155","journal-title":"Reumatismo"},{"issue":"10","key":"4378_CR20","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/art.1780381010","volume":"38","author":"VM Gonzalez","year":"1995","unstructured":"Gonzalez VM, Stewart A, Ritter PL, Lorig K (1995) Translation and validation of arthritis outcome measures into Spanish. Arthritis Rheum 38(10):1429\u20131446","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"4378_CR21","first-page":"79","volume":"112","author":"X Badia","year":"1999","unstructured":"Badia X, Roset M, Montserrat S, Herdman M, Segura A (1999) The Spanish version of EuroQol: a description and its applications. European Quality of Life Scale. Med Clin (Barc) 112(Suppl 1):79\u201385","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"4378_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 4(5):353\u2013365. \nhttps:\/\/doi.org\/10.2165\/00019053-199304050-00006","journal-title":"PharmacoEconomics"},{"key":"4378_CR23","unstructured":"Oblikue consulting eSalud\u2014Informaci\u00f3n econ\u00f3mica del sector sanitario (2017) \nhttp:\/\/esalud.oblikue.com\/\n\n. Accessed 10 Oct 2017"},{"key":"4378_CR24","unstructured":"Consejo General de Colegios Oficiales de Farmac\u00e9uticos Bot PLUS (2017) \nhttps:\/\/botplusweb.portalfarma.com\/\n\n. Accessed 10 Oct 2017"},{"key":"4378_CR25","unstructured":"Instituto Nacional de Estad\u00edstica (INE) (2017) Actualizaci\u00f3n de rentas con el IPC general (sistema IPC base 2016) para periodos anuales completos. \nhttp:\/\/www.ine.es\/\n\n. Accessed 10 Oct 2017"},{"key":"4378_CR26","unstructured":"Grupo de trabajo de la GUIPCAR (2011) Actualizaci\u00f3n de la Gu\u00eda de Pr\u00e1ctica Cl\u00ednica para el manejo de la artritis reumatoide en Espa\u00f1a. 2011. Sociedad Espa\u00f1ola de Reumatolog\u00eda, Doyma ed, Madrid"},{"key":"4378_CR27","unstructured":"Grupo de trabajo de la GUIPCAR (2018) Gu\u00eda de pr\u00e1ctica cl\u00ednica para el manejo de pacientes con artritis reumatoide. Sociedad Espa\u00f1ola de Reumatolog\u00eda, Madrid"},{"issue":"3","key":"4378_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1699-258X(08)71809-6","volume":"4","author":"L Carmona","year":"2008","unstructured":"Carmona L (2008) Cambios entre anti-TNF,\u00bf est\u00e1n siempre justificados? Reumatol Clin 4(3):87\u201389","journal-title":"Reumatol Clin"},{"key":"4378_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.reuma.2010.10.006","volume":"6","author":"A Balsa","year":"2011","unstructured":"Balsa A (2011) Definiendo la remisi\u00f3n en la artritis reumatoide: nuevos criterios de la ACR\/EULAR. Reumatol Clin 6:12\u201315","journal-title":"Reumatol Clin"},{"issue":"3","key":"4378_CR30","first-page":"112","volume":"32","author":"V Villaverde","year":"2005","unstructured":"Villaverde V, Hernandez-Garcia C, Gonzalez-Alvaro I, Vargas E, Abasolo L, Morado I, emAR gde (2005) Evaluaci\u00f3n cl\u00ednica de los pacientes con artritis reumatoide en Espa\u00f1a. Rev Esp Reumatol 32(3):112\u2013120","journal-title":"Rev Esp Reumatol"},{"issue":"4","key":"4378_CR31","first-page":"184","volume":"31","author":"F Navarro Sarabia","year":"2004","unstructured":"Navarro Sarabia F, Ballina Garc\u00eda F, Hern\u00e1ndez Cruz B, Hern\u00e1ndez Mej\u00eda R, Ruiz Montesinos M, Fern\u00e1ndez L\u00f3pez J, Ariza Ariza R, Mart\u00edn Lascuevas P, Carmona Ortell L (2004) Costes calidad de vida-artritis reumatoide. Estudio econ\u00f3mico y de la calidad de vida de los pacientes con artritis reumatoide en Espa\u00f1a. Resultados preliminares. Rev Espa\u00f1 Reumatol 31(4):184\u2013189","journal-title":"Rev Espa\u00f1 Reumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04378-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04378-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04378-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T23:12:43Z","timestamp":1596755563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04378-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4378"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04378-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]},"assertion":[{"value":"7 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Rubio reports speaker contributions for Lilly, Pfizer, Abbvie, Novartis, MSD, Celltrion, Sanofi, Roche, Gebro, Nordic, Grunenthal and UCB and was an advisor for Lilly, Sanofi, Biogen and Novartis. Dr G\u00f3mez-Centeno reportsspeaking fees from Pfizer, Lilly, Rubi\u00f3, Abbvie, Sanofi, Roche, Janssen, travel expenses covered from Pfizer, Abbvie, Lilly, and was an advisor for Pfizer, Abbvie,Lilly, Sanofi, Rubi\u00f3, Sandoz, Biogen and Gilead. Dr Gabriel Ovalles reports consultation and speaking fees from Abbvie, BMS, Celgene, Janssen, MSD, Novartis, Pfizer, Roche, Sanofi and UCB Pharma. Dr Manrique Arija reports speaking fees from Pfizer, Abbvie, MSD, UCB, Lilly, Novartis and Roche. Dr Marsal Barril was an advisor for Pfizer, Celgene, MSD, BMS, Abbvie, Sandoz, Novartis, Roche, UCB, Lilly, Sanofi and Janssen. Dr Amarelo Ramos reports speaking fees and consultancy from Sanofi and was an advisor for Novartis. Dr del Pino Montes reports consultancy from Amgen, Lilly, Pfizer, MSD, Abbvie, BMS, Novartis, Janssen and Sanofi. Dr Mu\u00f1oz-Fern\u00e1ndez reports speaking fees or was an advisor for MSD, Pfizer, Abbvie, Novartis, Janssen, UCB, Sanofi, Roche, Celgene and Gebro. Dr Bustabad was an advisor for Pfizer, AbbVie, Novartis, Sanofi, Roche, UCB and Janssen. Dr Barbaz\u00e1n \u00c1lvarez reports consultancy and expert testimony for Sanofi, Celgene, Novartis, Pfizer, Abbvie, Lilly, a grant from Janssen, speaker fees from Celgene, Sanofi, Novartis, Pfizer, Abbvie, Lilly and Roche, travel expenses covered from MSD, Abbvie, Lilly, Sanofi and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of Hospital Parc Taul\u00ed, Sabadell, approved the study protocol (study code DIREGL08326) and allowed the retrospective analysis of available records of the patients between 2013 and 2016. The study was conducted in accordance with the principles of the Declaration of Helsinki of 1975\/83.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}